Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.

Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.

<h4>Background</h4>Multiple Sclerosis (MS) is the first cause of non-traumatic neurological disability in young adults. Primary and secondary progressive MS are still lacking effective treatments. A new nutraceutical product made of lyophilised leaves of bioengineered kiwi plants (Actini...

Full description

Saved in:
Bibliographic Details
Main Authors: Viola Costa, Kenda Aluan, Irene Schiavetti, Caterina Bason, Tiziana Vigo, Elisa Leveraro, Corrado Cabona, Valeria Prada, Mauro Costagli, Vincenzo Daniele Boccia, Bruno Ruggiero, Giampaolo Brichetto, Marco Salvetti, Maria Pia Sormani, Gianluigi Mancardi, Matilde Inglese, Mario Alberto Battaglia
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0311214
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0311214

Similar Items